EXPEDITED REVIEW
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
A Randomized, Controlled Trial
Leonardo Calò, MD, FESC*,
Leopoldo Bianconi, MD,
Furio Colivicchi, MD, FESC,
Filippo Lamberti, MD,
Maria Luisa Loricchio, MD,
Ermenegildo de Ruvo, MD,
Antonella Meo, MD,
Claudio Pandozi, MD, FESC,
Mario Staibano, MD and
Massimo Santini, MD, FESC, FACC
Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
Manuscript received January 20, 2005;
revised manuscript received February 18, 2005,
accepted February 22, 2005.
* Reprint requests and correspondence: Dr. Leonardo Caló, Department of Cardiology, San Filippo Neri Hospital, Via della Pedica, 348, 00046 Grottaferrata, Rome, Italy (Email: leonardo.calo{at}tin.it).
OBJECTIVES: The aim of this study was to assess the efficacy of preoperative and postoperative treatment with n-3 polyunsaturated fatty acids (PUFAs) in preventing the occurrence of atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG).
BACKGROUND: Postoperative AF is a common complication of CABG. There is growing clinical evidence that PUFAs have cardiac antiarrhythmic effects.
METHODS: A total of 160 patients were prospectively randomized to a control group (81 patients, 13 female, 64.9 ± 9.1 years) or PUFAs 2 g/day (79 patients, 11 female, 66.2 ± 8.0 years) for at least 5 days before elective CABG and until the day of discharge from the hospital. The primary end point was the development of AF in the postoperative period. The secondary end point was the hospital length of stay after surgery. All end points were independently adjudicated by two cardiologists blinded to treatment assignment.
RESULTS: The clinical and surgical characteristics of the patients in the two groups were similar. Postoperative AF developed in 27 patients of the control group (33.3%) and in 12 patients of the PUFA group (15.2%) (p = 0.013). There was no significant difference in the incidence of nonfatal postoperative complications, and postoperative mortality was similar in the PUFA-treated patients (1.3%) versus controls (2.5%). After CABG, the PUFA patients were hospitalized for significantly fewer days than controls (7.3 ± 2.1 days vs. 8.2 ± 2.6 days, p = 0.017).
CONCLUSIONS: This study first demonstrates that PUFA administration during hospitalization in patients undergoing CABG substantially reduced the incidence of postoperative AF (54.4%) and was associated with a shorter hospital stay.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | CABG = coronary artery bypass graft surgery | | CI = confidence interval | | DHA = docosahexaenoic acid | | EPA = eicosapentaenoic acid | | OR = odds ratio | | PUFA = n-3 polyunsaturated fatty acid |
|
This article has been cited by other articles:

|
 |

|
 |
 
J. Sanchez-Quinones, F. Marin, V. Roldan, and G.Y.H. Lip
The impact of statin use on atrial fibrillation
QJM,
November 1, 2008;
101(11):
845 - 861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Widlicka
Enteral Nutrition in the Cardiothoracic Intensive Care Unit: Challenges and Considerations
Nutr Clin Pract,
October 1, 2008;
23(5):
510 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dorian and B. N. Singh
Upstream therapies to prevent atrial fibrillation
Eur. Heart J. Suppl.,
September 1, 2008;
10(suppl_H):
H11 - H31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian
Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death
Am. J. Clinical Nutrition,
June 1, 2008;
87(6):
1991S - 1996S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J.A. Jenkins, A. R. Josse, P. Dorian, M. L. Burr, R. LaBelle Trangmar, C. W.C. Kendall, and S. C. Cunnane
Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis, Secondary Prevention and Ventricular Arrhythmias
J. Am. Coll. Nutr.,
June 1, 2008;
27(3):
367 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kourliouros, A. De Souza, N. Roberts, A. Marciniak, A. Tsiouris, O. Valencia, J. Camm, and M. Jahangiri
Dose-related effect of statins on atrial fibrillation after cardiac surgery.
Ann. Thorac. Surg.,
May 1, 2008;
85(5):
1515 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-F. Xiao, D. C. Sigg, M. R. Ujhelyi, J. J. Wilhelm, E. S. Richardson, and P. A. Iaizzo
Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias
Am J Physiol Heart Circ Physiol,
May 1, 2008;
294(5):
H2212 - H2218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
J. Am. Coll. Cardiol.,
February 26, 2008;
51(8):
793 - 801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Fischer, R. Dechend, F. Qadri, M. Markovic, S. Feldt, F. Herse, J.-K. Park, A. Gapelyuk, I. Schwarz, U. B. Zacharzowsky, et al.
Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension
Hypertension,
February 1, 2008;
51(2):
540 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Albert, N. Halevy, and E. M. Antman
Preoperative Evaluation for Cardiac Surgery
Card. Surg. Adult,
January 1, 2008;
3(2008):
261 - 280.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Sakabe, A. Shiroshita-Takeshita, A. Maguy, C. Dumesnil, A. Nigam, T.-K. Leung, and S. Nattel
Omega-3 Polyunsaturated Fatty Acids Prevent Atrial Fibrillation Associated With Heart Failure but Not Atrial Tachycardia Remodeling
Circulation,
November 6, 2007;
116(19):
2101 - 2109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pepe and P. L. McLennan
(n-3) Long Chain PUFA Dose-Dependently Increase Oxygen Utilization Efficiency and Inhibit Arrhythmias after Saturated Fat Feeding in Rats
J. Nutr.,
November 1, 2007;
137(11):
2377 - 2383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian
Fish Oil and Prevention of Atrial Fibrillation
J. Am. Coll. Cardiol.,
October 9, 2007;
50(15):
1513 - 1514.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Sarrazin, G. Comeau, P. Daleau, J. Kingma, I. Plante, D. Fournier, and F. Molin
Reduced Incidence of Vagally Induced Atrial Fibrillation and Expression Levels of Connexins by n-3 Polyunsaturated Fatty Acids in Dogs
J. Am. Coll. Cardiol.,
October 9, 2007;
50(15):
1505 - 1512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. London, C. Albert, M. E. Anderson, W. R. Giles, D. R. Van Wagoner, E. Balk, G. E. Billman, M. Chung, W. Lands, A. Leaf, et al.
Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop
Circulation,
September 4, 2007;
116(10):
e320 - e335.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Cable
Invited commentary
Ann. Thorac. Surg.,
July 1, 2007;
84(1):
49 - 50.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L Baker and C M. White
Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies
Ann. Pharmacother.,
April 1, 2007;
41(4):
587 - 598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. von Schacky and W. S. Harris
Cardiovascular benefits of omega-3 fatty acids
Cardiovasc Res,
January 15, 2007;
73(2):
310 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian and E. B. Rimm
Fish intake, contaminants, and human health: evaluating the risks and the benefits.
JAMA,
October 18, 2006;
296(15):
1885 - 1899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
651 - 745.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
e149 - e246.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
e257 - e354.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Y H Lip and A. Tello-Montoliu
Management of atrial fibrillation.
Heart,
August 1, 2006;
92(8):
1177 - 1182.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L Breslow
n-3 Fatty acids and cardiovascular disease
Am. J. Clinical Nutrition,
June 1, 2006;
83(6):
S1477 - 1482S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Korantzopoulos, T. M. Kolettis, and J. A. Goudevenos
Effects of N-3 Fatty Acids on Postoperative Atrial Fibrillation Following Coronary Artery Bypass Surgery
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
467 - 468.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bianconi and L. Calo
Reply
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
468 - 468.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Boos, R. A. Anderson, and G. Y.H. Lip
Is atrial fibrillation an inflammatory disorder?
Eur. Heart J.,
January 2, 2006;
27(2):
136 - 149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Strauss, P. Dorian, and S. Verma
Fish Oil Supplementation and Arrhythmias
JAMA,
November 2, 2005;
294(17):
2165 - 2165.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Korantzopoulos, T. M. Kolettis, K. Siogas, and J. A. Goudevenos
The emerging role of inflammation in atrial fibrillation and the potential of anti-inflammatory interventions
Eur. Heart J.,
October 2, 2005;
26(20):
2207 - 2208.
[Full Text]
[PDF]
|
 |
|
|